Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
Clin Res Hepatol Gastroenterol
    April 2024
  1. HAN DG, Wang K, Liu W
    Gastric adenocarcinoma of fundic gland (chief cell predominant) type.
    Clin Res Hepatol Gastroenterol. 2024;48:102306.
    >> Share

    January 2024
  2. HAN X, Jia X, Sheng C, Li M, et al
    A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer.
    Clin Res Hepatol Gastroenterol. 2024 Jan 20:102287.
    >> Share

  3. XU Y, Song Y, Zhang B, Yang Y, et al
    Clinicopathological characteristics of crawling-type gastric adenocarcinoma.
    Clin Res Hepatol Gastroenterol. 2024;48:102262.
    >> Share

  4. MARTIN A, Jauvain M, Bergsten E, Demontant V, et al
    Gastric microbiota in patients with gastric MALT lymphoma according to Helicobacter pylori infection.
    Clin Res Hepatol Gastroenterol. 2024;48:102247.
    >> Share

    November 2023
  5. DEPOTTE L, Palle J, Rasola C, Broudin C, et al
    New developments and standard of care in the management of advanced gastric cancer.
    Clin Res Hepatol Gastroenterol. 2023 Nov 10:102245.
    >> Share

    August 2023
  6. DU C, He Z, Li L, Ning B, et al
    Endoscopic resection for the treatment of non-gastric gastrointestinal stromal tumors: A retrospective study from a large tertiary hospital in China.
    Clin Res Hepatol Gastroenterol. 2023;47:102152.
    >> Share

    January 2023
  7. WANG M, Su J, Lu J, Yang Z, et al
    Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?
    Clin Res Hepatol Gastroenterol. 2023;47:102078.
    >> Share

    December 2022
  8. YUAN H, Duan DD, Zhang YJ
    Comprehensive analysis of treatment-related adverse events of immunotherapy in advanced gastric or gastroesophageal junction cancer: A meta-analysis of randomized controlled trials.
    Clin Res Hepatol Gastroenterol. 2022;46:102031.
    >> Share

    October 2022
  9. WU H, Jiang HJ, Wang SL, Chen XY, et al
    Impact of metabolic syndrome on the short- and long-term outcomes for the elderly patients with gastric cancer after radical gastrectomy.
    Clin Res Hepatol Gastroenterol. 2022;46:102041.
    >> Share

    May 2022
  10. MA N, Qiao H, Tao H, Gan X, et al
    Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients.
    Clin Res Hepatol Gastroenterol. 2022 May 27:101962.
    >> Share

  11. SIRMAI L, Benusiglio PR, Svrcek M, Dray X, et al
    Magnifying chromoendoscopy with targeted biopsies of intramucosal signet cell adenocarcinomas in a CDH1 pathogenic variant asymptomatic carrier.
    Clin Res Hepatol Gastroenterol. 2022;46:101914.
    >> Share

    April 2022
  12. CARBONI F, Zazza S, Bertini L, Diodoro MG, et al
    Remarkable survival of operated stage IV gastric cancer with resected late isolated colon metastasis.
    Clin Res Hepatol Gastroenterol. 2022 Apr 7:101917.
    >> Share

  13. NG HI, Li ZQ, Zhang YM, Hu CF, et al
    Gastric inverted hyperplastic polyp, an exceptional case diagnosed after endoscopic submucosal dissection.
    Clin Res Hepatol Gastroenterol. 2022;46:101890.
    >> Share

    March 2022
  14. HE T, Yu D, Wang Z, Guo C, et al
    Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: a long-term follow-up study.
    Clin Res Hepatol Gastroenterol. 2022 Mar 25:101913.
    >> Share

  15. LI J, Huang WF, Zhang JY
    A rare case of duodenal neuroendocrine tumor with hepatic metastasis.
    Clin Res Hepatol Gastroenterol. 2022;46:101850.
    >> Share

  16. JENVRIN A, Lepine C, Bozec PL, Taieb J, et al
    Atypical cutaneous metastases of poorly cohesive carcinoma of the stomach: Letter to the editor.
    Clin Res Hepatol Gastroenterol. 2022;46:101795.
    >> Share

    October 2021
  17. TAJA-CHAYEB L, Vidal-Millan S, Trejo-Becerril C, Perez-Cardenas E, et al
    Hereditary Diffuse Gastric Cancer (HDGC). An overview.
    Clin Res Hepatol Gastroenterol. 2021 Oct 14:101820.
    >> Share

    September 2021
  18. BOEKEN T, Gallois C, Douard R, Meatchi T, et al
    Bridge to surgery after irinotecan-based liver chemoembolization for metastatic gastric adenocarcinoma: Letter to the editor.
    Clin Res Hepatol Gastroenterol. 2021;45:101557.
    >> Share

    July 2021
  19. LIU H, Liu M, He B, Li Q, et al
    Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways.
    Clin Res Hepatol Gastroenterol. 2021 Jul 28:101779.
    >> Share

  20. TRAN-MINH ML, Lehmann-Che J, Lambert J, Theou-Anton N, et al
    Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01.
    Clin Res Hepatol Gastroenterol. 2021;45:101691.
    >> Share

    June 2021
  21. HOU B, Wang P, Liu T, Chen S, et al
    Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors.
    Clin Res Hepatol Gastroenterol. 2021 Jun 25:101748.
    >> Share

    May 2021
  22. DOUMBE-MANDENGUE P, Beuvon F, Belle A, Dermine S, et al
    Outcomes of endoscopic submucosal dissection for early esophageal and gastric cardia adenocarcinomas.
    Clin Res Hepatol Gastroenterol. 2021;45:101700.
    >> Share

    March 2021
  23. BU X, Chen Z, Zhang A, Zhang X, et al
    Circular RNA CircAFF2 Accelerates Gastric Cancer Development by Activating MiR-6894-5p and Regulating ANTXR 1 Expression.
    Clin Res Hepatol Gastroenterol. 2021 Mar 12:101671.
    >> Share

  24. JIN P, Ji X, Ma S, Kang W, et al
    Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node.
    Clin Res Hepatol Gastroenterol. 2021;45:101634.
    >> Share

    January 2021
  25. CARBONE R, Vanoli A, Rovedatti L, Lucioni M, et al
    Epstein-Barr virus negative smooth muscle neoplasm of the stomach in a young woman.
    Clin Res Hepatol Gastroenterol. 2021;45:101471.
    >> Share

    November 2020
  26. YAN XL, Luo QY, Zhou SN, Pan WT, et al
    MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.
    Clin Res Hepatol Gastroenterol. 2020 Nov 30:101574.
    >> Share

  27. LU J, Ma Y, Zhao Z
    MiR-142 suppresses progression of gastric carcinoma via directly targeting LRP8.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101520.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016